Phase I/II study of LYS-GM101 for treatment of GM1 Gangliosidosis
Phase of Trial: Phase I/II
Latest Information Update: 24 May 2017
At a glance
- Drugs LYS GM101 (Primary)
- Indications Gangliosidoses
- Focus Adverse reactions; Therapeutic Use
- 24 May 2017 According to a Lysogene media release, the phase I trial is expected to begin in 2019.
- 02 Feb 2017 According to a LYSOGENE media release, company is planning to start this trial by the end of the first half of 2018.
- 20 Jan 2017 New trial record